Source: Annual Congress 2011 - The best abstracts in rehabilitation and chronic care 2011 (sponsored by Nutricia Advanced Medical Nutrition)
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
B. van den Borst, H. Gosker, A. Koster, S. Kritchevsky, Y. Liu, B. Meibohm, T. Rice, M. Shlipak, T. Harris, A. Schols (Maastricht, Netherlands; Bethesda, Winston-Salem, Memphis, Pittsburgh, San Francisco, United States Of America). Obstructive lung disease is associated with increased abdominal visceral fat and elevated systemic adipocytokines. Eur Respir J 2011; 38: Suppl. 55, 1887

Member's Comments

No comment yet.

Related content which might interest you: Metabolic syndrome and visceral adipose tissue (VAT) are associated with obstructive and restrictive lung function impairment. Source: Virtual Congress 2020 – Mechanism or pathways of chronic lung diseases Year: 2020 Visceral adiposity index in patients with chronic obstructive pulmonary disease Source: International Congress 2018 – Interdependence of COPD and comorbidities and the underlying mechanisms Year: 2018 Relationship between osteoporosis and adipose tissue leptin and osteoprotegerin in patients with chronic obstructive pulmonary disease Source: Annual Congress 2011 - COPD mechanisms Year: 2011 Significant associations between obstructive sleep apnea and fat accumulation in the liver in male subjects without visceral obesity Source: Annual Congress 2013 –A metabolic medley: sleep disordered breathing Year: 2013 Metabolic phenotype and adipose tissue inflammation in patients with chronic obstructive pulmonary disease Source: Annual Congress 2011 - COPD mechanisms Year: 2011 Metabolic aspects of obstructive sleep apnoea syndrome Source: Eur Respir Rev 2009; 18: 113-124 Year: 2009 Leptin, visfatin, insulin resistance, body composition change in chronic obstructive pulmonary disease Source: Annual Congress 2010 - COPD: phenotyping and monitoring Year: 2010 Reduced number of subcutaneous adipocytes and metabolic disorders in patients with pulmonary emphysema. Source: International Congress 2019 – Comorbidities in COPD and asthma: body composition and diabetes Year: 2019 Effects of 8 weeks of continuous positive airway pressure on abdominal adiposity in obstructive sleep apnoea}, Source: Eur Respir J 2012; 40: 913-918 Year: 2012 Osteoporosis and adipose tissue expression of adipokines and osteoprotegerin in severe chronic obstructive pulmonary disease Source: Annual Congress 2013 –COPD: acute exacerbations and others Year: 2013 Body composition and plasma levels of inflammatory biomarkers in COPD Source: Eur Respir J 2010; 36: 1027-1033 Year: 2010 Intermittent hypoxia in obstructive sleep apnoea mediates insulin resistance through adipose tissue inflammation Source: Eur Respir J , 49 (4)  1601731; DOI: 10.1183/13993003.01731-2016 Year: 2017 Associations between variations of adipokines, cytokines and body composition in patients with chronic obstructive pulmonary disease in one year Source: International Congress 2018 – Nutrition and metabolic syndrome in COPD Year: 2018 Adipose tissue in obesity and obstructive sleep apnoea Source: Eur Respir J 2012; 39: 746-767 Year: 2012 Leptin in relation to systemic inflammation and regulation of the energy balance Source: ISSN=1025-448x, ISBN=1-904097-27-8, page=56 Year: 2003 Associations between increased serum leptin levels and the severity of obstructive sleep apnoea independent of obesity Source: Annual Congress 2009 - Systemic consequences of sleep-disordered breathing Year: 2009 Low lung volume is associated with visceral adipose tissue inflammation Source: Annual Congress 2013 –Clinical physiology and functional imaging in health and disease Year: 2013 Visceral fat in non-to-moderate and severe obstructive sleep apnoea Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA I Year: 2012 Correlation between peritoneal fat and mid-thigh fat in chronic respiratory patients Source: International Congress 2018 – Nutrition and metabolic syndrome in COPD Year: 2018 Oxygen therapy decreases systemic inflammation in patients with chronic obstructive pulmonary disease and hypoxemia Source: Annual Congress 2010 - Novel anti-inflammatory agents for airway disease Year: 2010